NR4A1 and breast cancer: At the molecular level, breast cancer presents as a heterogeneous disease characterized by various molecular features, including the activation of the human epidermal growth factor receptor 2 (HER2, encoded by ERBB2), the activation of hormone receptors (such as the estrogen receptor and progesterone receptor), and/or mutations in the BRCA genes [1].